Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biotechnology Companies in 2024
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.
  1. Albireo Pharma

    World Rank (Jan-05-2024)
    13,865
    World Rank (Jul-30-2023)
    13,865
    Market Cap (Jul-30-2023)
    0.921 Billion USD
    World Rank (Dec-25-2022)
    13,865
    Market Cap (Dec-25-2022)
    0.401 Billion USD
    World Rank (Jan-07-2022)
    13,446
    Market Cap (Jan-07-2022)
    0.50 Billion USD
    Annual Revenue in USD
    40 Million USD
    Annual Net Income in USD
    -34 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Albireo is a Clinical Stage Biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases and other adult liver diseases and disorders. The company annual revenue is 8.3 million USD and 55 employees as on 2020. The headquarters is in USA.

  2. Hyloris Pharmaceuticals SA

    World Rank (Jan-05-2024)
    13,898
    Market Cap (Jan-05-2024)
    0.404 Billion USD
    World Rank (Jul-30-2023)
    14,734
    Market Cap (Jul-30-2023)
    0.364 Billion USD
    World Rank (Dec-25-2022)
    14,529
    Market Cap (Dec-25-2022)
    0.363 Billion USD
    World Rank (Jan-07-2022)
    13,031
    Market Cap (Jan-07-2022)
    0.54 Billion USD
    Headquarters Country
  3. SIGA Technologies

    World Rank (Jan-05-2024)
    13,959
    Market Cap (Jan-05-2024)
    0.400 Billion USD
    World Rank (Jul-30-2023)
    14,141
    Market Cap (Jul-30-2023)
    0.398 Billion USD
    World Rank (Dec-25-2022)
    11,614
    Market Cap (Dec-25-2022)
    0.567 Billion USD
    World Rank (Jan-07-2022)
    13,249
    Market Cap (Jan-07-2022)
    0.52 Billion USD
    Annual Revenue in USD
    133 Million USD
    Annual Net Income in USD
    69 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    SIGA Technologies is a Public and Commercial Stage Pharmaceutical company focused on providing solutions for unmet needs in the health security market that comprises medical countermeasures against chemical, biological, radiological and nuclear (CBRN) threats as well as emerging infectious diseases. The company annual revenue is 127.2 million USD and 41 employees as on 2020. The headquarters is in USA.

  4. iTeos Therapeutics Inc.

    World Rank (Jan-05-2024)
    13,965
    Market Cap (Jan-05-2024)
    0.400 Billion USD
    World Rank (Jul-30-2023)
    12,768
    Market Cap (Jul-30-2023)
    0.499 Billion USD
    World Rank (Dec-25-2022)
    10,597
    Market Cap (Dec-25-2022)
    0.669 Billion USD
    World Rank (Jan-07-2022)
    7,393
    Market Cap (Jan-07-2022)
    1.52 Billion USD
    Annual Revenue in USD
    344 Million USD
    Annual Net Income in USD
    214 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    iTeos Therapeutics is a Clinical Stage Biopharmaceutical Company pioneering the discovery and development of a new generation of highly differentiated immuno oncology therapeutics for patients. It innovative pipeline includes two clinical stage programs targeting novel, validated immuno oncology pathways designed to build on prior learnings in the field to have differentiated pharmacological and clinical profiles. The headquarters is in USA.
  5. PDL Biopharma

    World Rank (Jan-05-2024)
    13,968
    World Rank (Jul-30-2023)
    13,968
    World Rank (Dec-25-2022)
    13,968
    World Rank (Jan-07-2022)
    13,968
    Annual Revenue in USD
    54 Million USD
    Annual Net Income in USD
    4 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  6. Mereo Biopharma Group

    World Rank (Jan-05-2024)
    13,973
    Market Cap (Jan-05-2024)
    0.400 Billion USD
    World Rank (Jul-30-2023)
    19,766
    Market Cap (Jul-30-2023)
    0.145 Billion USD
    World Rank (Dec-25-2022)
    23,476
    Market Cap (Dec-25-2022)
    0.070 Billion USD
    World Rank (Jan-07-2022)
    20,131
    Market Cap (Jan-07-2022)
    0.16 Billion USD
    Headquarters Country
  7. 23andMe Holding Co.

    World Rank (Jan-05-2024)
    13,988
    Market Cap (Jan-05-2024)
    0.399 Billion USD
    World Rank (Jul-30-2023)
    9,578
    Market Cap (Jul-30-2023)
    0.849 Billion USD
    World Rank (Dec-25-2022)
    8,329
    Market Cap (Dec-25-2022)
    1.007 Billion USD
    World Rank (Jan-07-2022)
    5,045
    Market Cap (Jan-07-2022)
    2.84 Billion USD
    Annual Revenue in USD
    271 Million USD
    Annual Net Income in USD
    -217 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile
    23andMe is the technology to genotype and Biotechnology company. The headquarters is in USA.
    Facts About Company
    23andMe company annual revenue was 299 million USD and annual net loss was -311 as on Mar-2023.
  8. Biotech Growth Trust (The)

    World Rank (Jan-05-2024)
    14,062
    Market Cap (Jan-05-2024)
    0.395 Billion USD
    World Rank (Jul-30-2023)
    14,397
    Market Cap (Jul-30-2023)
    0.383 Billion USD
    World Rank (Dec-25-2022)
    13,065
    Market Cap (Dec-25-2022)
    0.453 Billion USD
    World Rank (Jan-07-2022)
    12,307
    Market Cap (Jan-07-2022)
    0.60 Billion USD
    Annual Revenue in USD
    -246 Million USD
    Annual Net Income in USD
    -238 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile
    Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry company. It is an investment manager focused exclusively on the healthcare sector with approximately U.S.$13billion in assets under management as at 31 March 2019 across a range of funds, including investment trusts, hedge funds and private equity funds. The headquarters is in UK.
  9. Lexicon Pharmaceuticals

    World Rank (Jan-05-2024)
    14,138
    Market Cap (Jan-05-2024)
    0.390 Billion USD
    World Rank (Jul-30-2023)
    12,951
    Market Cap (Jul-30-2023)
    0.485 Billion USD
    World Rank (Dec-25-2022)
    14,430
    Market Cap (Dec-25-2022)
    0.368 Billion USD
    World Rank (Jan-07-2022)
    13,051
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -87 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Lexicon Pharmaceuticals is a Biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize winning technology to discover and develop precise medicines for people with serious, chronic conditions. The company annual revenue is 322.07 million USD and 202 employees as on 2019. The headquarters is in USA.

Share

Ads